Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet Neurology.
Apr 13, 2024
0
3
A rising number of measles cases in the U.S. this year is raising concerns over a comeback of a disease that was declared eliminated in this country 24 years ago.
Apr 15, 2024
0
0
Recent research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by ...
Apr 10, 2024
0
5
A study conducted at the Faculty of Sport and Health Sciences at the University of Jyväskylä showed that a genetic predisposition for higher muscle strength predicts a longer lifespan and a lower risk for developing common ...
Apr 12, 2024
0
2
A new paper in JNCI Cancer Spectrum finds that following a healthy diet lowers the risk of cardiovascular disease in breast cancer survivors.
23 hours ago
0
38
A new mathematical model offers hope for better prediction and treatment of Alzheimer's disease. Most mathematical models of Alzheimer's are theoretical, focusing on short term molecular and cellular-level changes that cannot ...
Apr 11, 2024
0
3
Low-cost, wearable sensors could increase access to care for patients with Parkinson's disease. New machine-learning approaches and a baseline of data from healthy older adults improve the accuracy of the results from such ...
Apr 12, 2024
0
0
Cortisone and other related glucocorticoids are extremely effective at curbing excessive immune reactions. But previously, astonishingly little was known about how they exactly do that. A team of researchers from Charité—Universitätsmedizin ...
Apr 10, 2024
0
54
Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a ...
Apr 16, 2024
0
41
In a world-first, QIMR Berghofer scientists have discovered the mechanism that causes severe inflammation among millions of people with chronic liver disease.
Apr 12, 2024
0
15
